VCCC Alliance Breast Cancer Educational Series

What you will learn

Recent advancements in sentinel node biopsy mean that many patients can avoid lymphoedema, a common side effect of axillary lymph node dissection (ALND). Surgical de-escalation has also proven to have equivalent oncological outcomes with reduced complications. Currently axillary radiotherapy is increasingly used as an alternative to ALND, however the increasing use of neoadjuvant chemotherapy adds further complexity.

Join an expert panel of surgeons from across Australia and New Zealand for a close look at axillary dissection and de-escalating axillary surgery after neoadjuvant chemotherapy, with opportunity for discussion.  

Aim: To discuss axillary dissection and de-escalating axillary surgery after neoadjuvant chemotherapy. 

Learning Objective: To explore recent advancements in sentinel node biopsy and de-escalating axillary surgery after neoadjuvant chemothera

The VCCC Alliance Breast Cancer Education Series is targeted at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic. It is not appropriate for consumer participants.

Additional information

This event is hosted in conjunction with the Breast Surgeons of Australia and New Zealand (BreastSurgANZ).